None listed
Conditions
Brief summary
To address inefficiencies and improve data collection, analysis and display, a bespoke clinical decision support system (CDSS) was developed - www.lymbase.com. This CDSS is now ready for implementation in the NSW public health system and this study will evaluate the implementation process. The anticipated outcome of the study will see refinement of the CDSS and processes to support implementation of Lymbase® for public health sector use.
Interventions
This study is an evaluation of the implementation of a bespoke lymphoedema clinical decision support system (CDSS) - www.lymbase.com into three health districts in NSW. The CDSS (Lymbase) stores patient data relevant to lymphoedema assessment and treatment including clinician reported and patient reported outcomes. It automates calculations for circumference measures and provides a visual display of size change. Lymbase also provides an easy-to-use compression garment search function, accessible for trained lymphoedema therapists. During the trial period clinicians will use the CDSS for all consenting patients. In Stage 1 occurring over four months (intervention period) the pilot study in Sydney Local Health District, will evaluate implementation for patients and clinicians. Revisions based on these findings will be undertaken before rolling the CDSS out in a further three Health Districts (4 month intervention period) and re-evaluating. These revisions might be to the user experience or content of the platform; or they might be to supporting systems such as the website, contact form, explainer videos, etc. The CPI will undertake a site visit for each site to provide participants with a tablet and access to the software for clinical use in order to provide feedback on the implementation and the CDSS. In addition to semi-structured interviews with clinicians and questionnaires with patients and clinicians an audit of utilisation, including feature utilisation will be undertaken. A single site pre-post survey will explore the patient experience.
Sponsors
Study design
Eligibility
Inclusion criteria
There are two participant groups. i) Clinicians registered/registerable as lymphoedema therapists as per the Australasian Lymphology Association guidelines employed in the participating local health districts ii) Patients attending lymphoedema services in the local health districts who have been assessed (including circumference measurements on at least three other occasions.
Exclusion criteria
The CPI, although fitting the criteria for inclusion as a clinician participant has been excluded based on conflict of interest.